Lords Mark Industries Ltd. has attained US FDA registration for its comprehensive portfolio of surgical consumables, orthopedic supports, and hygiene products. This pivotal achievement not only validates the company’s commitment to manufacturing excellence but also enhances India’s growing influence in the global healthcare manufacturing ecosystem.
Securing US FDA registration signifies adherence to the most rigorous standards of product safety, quality, and regulatory compliance. For Indian producers, this opens critical access to high-potential, strictly regulated markets such as the United States, European Union, and the Middle East — paving the way for accelerated international growth. For Lords Mark, this milestone is a cornerstone in its mission to expand its global reach and contribute meaningfully to India’s aspirations as a world-class medical manufacturing hub.
A Broad Range of Certified Healthcare Solutions
The FDA-approved product range spans multiple categories:
Surgical Consumables: Cotton Crepe Bandages, Elastic Adhesive Bandages, Cannula Fixators, Disinfectant Wet Wipes
Orthopedic and Rehabilitation Aids: Abdominal and rib belts, cervical collars, lumbar supports, Taylor’s brace, cockup splints, arm slings, knee and shoulder immobilizers
Hygiene Range (Lord’s Joy brand): Baby wipes, bed bath wipes, and refreshing wipes
Cutting-Edge Manufacturing Capabilities
This accomplishment is powered by Lords Mark Industries’ advanced manufacturing facility located in Dadra & Nagar Haveli. The site houses five integrated divisions, employs over 100 skilled professionals, and incorporates precision-engineered systems to ensure consistency and scalability.
Key features include:
- Compliance with the 5S methodology for efficiency
- Multi-tiered Quality Control & Quality Assurance systems
- High-performance machinery: 5 loom machines, TFO & cheese winders, warping and dyeing sections, 38 stitching units, and an automated adhesive coating line
The facility aligns with the global standards of ISO 13485:2016, WHO-GMP, CDSCO, cGMP, GLP, Indian FDA, and now, the US FDA—guaranteeing that each product meets international benchmarks.
Transforming Logistics Through Technology
Beyond production, the company has revolutionized its logistics infrastructure. By leveraging digitally integrated and real-time tracking systems, Lords Mark ensures accurate and efficient delivery across both domestic and export territories. Its predictive logistics model employs data analytics for route optimization, traceability, and quicker dispatches — reducing turnaround time and logistical costs.
The company’s internal six-tier Quality Excellence Framework supports this transformation through:
- Clear specification development
- Step-wise product testing
- Team training programs
- Performance measurement
- Root-cause corrections
- Ongoing process improvements
Every employee is committed to this operational philosophy, making “Hamesha Aapke Saath” more than a slogan — it is the foundation of daily business conduct.
Leadership Insights and Strategic Vision
Mr. Sachidanand Upadhyay, Managing Director, shared:
“We aim to take India’s high-quality, cost-effective healthcare solutions to the global stage.” The US FD approval empowers us to take Indian excellence to the world confidently.”
Mr. Manav Teli, Executive Director, added:
“This approval reflects our unwavering commitment to excellence and continuous innovation.” By investing in automation, stringent QC, and smart supply chain systems, we are laying the groundwork for a fast, transparent, and tech-driven global healthcare network.”
Guided by Mr. Teli and Business Head, Mr. Niraj Oza, the company continues to drive forward with a focus on automation, R&D-led development, and sustainable manufacturing practices.
Positioning India on the World Map
Already operating a U.S. subsidiary — Lords Mark Global LLC based in Texas — the company now joins the elite group of Indian healthcare manufacturers with US FDA recognition, alongside industry leaders like Sun Pharma, Dr. Reddy’s, Cipla, Biocon, Meril Life Sciences, and Poly Medicure.
This accomplishment underscores India’s growing dominance, with over 700 FDA-registered facilities, as a trusted source of high-quality, compliant, and cost-effective healthcare solutions worldwide.